Target intelligence / Profile preview

Nidoviral papain-like protease (PLPro)

Target
PLPro
Molecular classification
Enzyme, Cysteine protease, Viral polyprotein-processing protease, Deubiquitinating enzyme (DUB), Clan CA, family C16 (MEROPS classification)
01

Overview

Nidoviral papain-like proteases are viral cysteine proteases encoded by nidoviruses—including all coronaviruses—that play a critical role in the cleavage of the N-terminal region of large viral polyproteins during virus replication. This processing is essential for generating functional nonstructural proteins required for RNA synthesis. The best-studied examples are found in SARS-CoV, SARS-CoV‑2, and MERS-CoV. In addition to their primary role as endopeptidases cleaving specific sites within the replicative polyprotein, these enzymes also function as deubiquitinating enzymes (DUBs) and deISGylating enzymes, removing ubiquitin or ISG15 modifications from host cell proteins. These activities help viruses evade innate immune responses by interfering with key signaling pathways involved in antiviral defense. Structurally, nidoviral papain-like proteases share a fold similar to cellular papain but have unique features such as an intact zinc-binding motif and a specialized substrate recognition site that accommodates both peptide bonds within the viral polyprotein and isopeptide bonds linking ubiquitin/ISG15 to target proteins. The active site typically contains a catalytic triad composed of cysteine, histidine, and aspartate residues. Because they are essential for both viral maturation and suppression of host immunity—and because their structure differs sufficiently from most human homologues—these enzymes are considered high-priority targets for antiviral drug development against diseases like COVID‑19. Several small-molecule inhibitors have been identified preclinically; however, none have yet reached widespread clinical use. Alternative names include "papain-like proteinase," "PLPro," "PLP," or more specifically "coronavirus papain-like peptidase." When multiple domains exist within one virus genome they may be referred to numerically (e.g., PLP1/PLP2). Their molecular classification places them among clan CA cysteine endopeptidases per MEROPS nomenclature.

Other names
Papain-like proteaseCoronavirus papain-like peptidasePLProPLPPapain-like proteinaseDeubiquitinating enzyme of coronaviruses
02

Mechanism of action

Inhibition of the cysteine protease activity to block viral polyprotein processing, thereby halting viral replication; Inhibition of deubiquitinase/deISGylating activity to restore or enhance host antiviral immune responses

03

Biological functions

Proteolytic cleavage of viral polyproteins for viral maturation and replicationRemoval of ubiquitin and ISG15 from host proteins (deubiquitination and deISGylation)Antagonism of host innate immune response
04

Disease associations

Infection (especially coronavirus infections such as SARS, MERS, COVID‑19)
05

Safety considerations

Potential off-target effects due to similarity with human deubiquitinases/cysteine proteasesRisk that inhibition could affect normal cellular ubiquitin/ISG15 pathways if selectivity is insufficient
06

Interacting drugs

GRL0617 and its derivatives

1 more in the full profile.

07

Biomarkers

No established clinical biomarkers specific for patient selection or efficacy monitoring; research ongoing into changes in levels/activity during infection or treatment response

Beyond the preview

Go deeper on Nidoviral papain-like protease (PLPro).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nidoviral papain-like protease (PLPro).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call